Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$8.63 - $12.56 $189,514 - $275,817
21,960 Added 147.57%
36,841 $343,000
Q1 2024

May 14, 2024

SELL
$9.86 - $13.74 $14,454 - $20,142
-1,466 Reduced 8.97%
14,881 $184,000
Q4 2023

Feb 12, 2024

SELL
$7.1 - $10.89 $16,003 - $24,546
-2,254 Reduced 12.12%
16,347 $178,000
Q3 2023

Nov 13, 2023

SELL
$6.95 - $9.89 $60,763 - $86,468
-8,743 Reduced 31.97%
18,601 $148,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $13,116 - $22,233
1,527 Added 5.91%
27,344 $262,000
Q1 2023

May 12, 2023

BUY
$9.53 - $16.8 $105,640 - $186,228
11,085 Added 75.24%
25,817 $309,000
Q4 2022

Feb 14, 2023

SELL
$8.71 - $14.28 $70,010 - $114,782
-8,038 Reduced 35.3%
14,732 $204,000
Q3 2022

Nov 10, 2022

SELL
$7.19 - $9.91 $50,624 - $69,776
-7,041 Reduced 23.62%
22,770 $207,000
Q2 2022

Aug 10, 2022

BUY
$5.78 - $8.87 $172,307 - $264,423
29,811 New
29,811 $238,000
Q1 2021

Jul 21, 2021

SELL
$12.28 - $19.74 $123,536 - $198,584
-10,060 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$11.65 - $17.94 $407,237 - $627,110
-34,956 Reduced 77.65%
10,060 $135,000
Q3 2020

Oct 30, 2020

BUY
$12.98 - $25.98 $214,066 - $428,462
16,492 Added 57.82%
45,016 $786,000
Q2 2020

Aug 05, 2020

SELL
$9.06 - $23.49 $55,410 - $143,664
-6,116 Reduced 17.66%
28,524 $709,000
Q1 2020

May 11, 2020

SELL
$7.2 - $13.09 $161,294 - $293,242
-22,402 Reduced 39.27%
34,640 $383,000
Q4 2019

Feb 13, 2020

BUY
$6.94 - $11.37 $194,708 - $318,996
28,056 Added 96.79%
57,042 $449,000
Q3 2019

Nov 08, 2019

BUY
$6.69 - $9.65 $193,916 - $279,714
28,986 New
28,986 $276,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $309M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.